Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
Public ClinicalTrials.gov record NCT00257660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.
Study identification
- NCT ID
- NCT00257660
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 116 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 10, 2005 (Actual)
- Primary completion
- Sep 2006 (Actual)
- Completion
- Sep 2006 (Actual)
- Last update posted
- Sep 28, 2022
2005 – 2006
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | — | — |
| Parkinson's and Movement Disorder Institute | Fountain Valley | California | — | — |
| USC School of Medicine | Los Angeles | California | 90033 | — |
| University of Florida | Gainesville | Florida | — | — |
| University of Miami | Miami | Florida | — | — |
| Emory University | Atlanta | Georgia | — | — |
| Rush University Medical Center | Chicago | Illinois | — | — |
| University of Iowa | Iowa City | Iowa | — | — |
| University of Maryland Medical Center | Baltimore | Maryland | — | — |
| Wayne State University Medical Center | Southfield | Michigan | — | — |
| Albany Medical Center | Albany | New York | — | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Columbia University | New York | New York | — | — |
| Wake Forest University | Winston-Salem | North Carolina | — | — |
| Allegeheny General | Pittsburgh | Pennsylvania | — | — |
| University of Texas Southwest | Dallas | Texas | — | — |
| Baylor College of Medicine | Houston | Texas | — | — |
| Swedish Neuroscience | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00257660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2022 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00257660 live on ClinicalTrials.gov.